Guidance on use of non-invasive remote monitoring devices for patient care during the coronavirus public health emergency was expanded and updated by the US Food and Drug Administration (FDA) on ...
A buzzword at the 2023 International Boat Builders Expo (IBEX) was “telematics.” Marine telematics refers to app-based systems that enable remote boat monitoring, including boat locations, speed, ...
The US Food and Drug Administration (FDA) has updated final guidance on its enforcement policy for remote patient monitoring devices in an effort to assist stakeholders in transitioning operations and ...
It’s an increasingly common posttreatment occurrence: Patients with hypertension or diabetes return home with new blood pressure or glucose monitors, allowing clinicians to keep tabs on patient ...
Many of the latest advances in remote monitoring for digital healthcare revolve around non-invasive devices and innovative technologies that reduce patient care costs while improving health outcomes.
Obtaining real-time operating data on power plant and substation equipment has never been easier. The sensors, transmitters, and systems needed to monitor important parameters are readily available ...
A community-based remote patient monitoring (RPM) program was associated with significant reduction in blood pressure in Medicare patients with stage 2 hypertension, highlighting the potential ...
This review article presents a three-part true-life clinical vignette that illustrates how digital health technology can aid providers caring for patients with cardiovascular disease. Specific ...
The need for remote monitoring technology is growing, driven by legislative, environmental and operational forces that make continual data collection a critical matter for many organisations. However, ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...
In what some industry observers saw as a setback for at-home patient monitoring, FDA's Circulatory System Devices Panel rejected the premarket approval application (PMA) for the Chronicle implantable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results